Coronavirus disease-19 is global healthcare crisis. Till May 20, 2020, there were
approximately 4,789,205 cases and 318,789 related mortalities were identified globally. This
dramatic situation led to healthcare service collapse in many countries. Each country
developed its own action plan depending on healthcare expertise and the available resources.
There is no definitive therapy for Coronavirus disease-19 up till now. Many current and
investigational drugs are used nowadays. Recent reports suggest a beneficial role of
Ivermectin in the management of Coronavirus disease-19. A notice that necessitates further
clinical studies.
The aim of this study is to assess the efficacy and safety of the usage of inhaled ivermectin
in the management of Coronavirus disease-19.